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Neurons require efficient transport mechanisms such as
fast axonal transport to ensure neuronal homeostasis and
survival. Neurotrophins and their receptors are conveyed
via fast axonal retrograde transport of signaling endo-
somes to the soma, where they elicit transcriptional re-
sponses. Despite the essential roles of signaling endo-
somes in neuronal differentiation and survival, little is
known about their molecular identity, dynamics, and reg-
ulation. Gaining a better mechanistic understanding of
these organelles and their kinetics is crucial, given the
growing evidence linking vesicular trafficking deficits to
neurodegeneration. Here, we exploited an affinity purifi-
cation strategy using the binding fragment of tetanus neu-
rotoxin (HCT) conjugated to monocrystalline iron oxide
nanoparticles (MIONs), which in motor neurons, is trans-
ported in the same carriers as neurotrophins and their
receptors. To quantitatively assess the molecular compo-
sition of HCT-containing signaling endosomes, we have
developed a protocol for triple Stable Isotope Labeling
with Amino acids in Cell culture (SILAC) in embryonic
stem cell-derived motor neurons. After HCT internaliza-
tion, retrograde carriers were magnetically isolated at
different time points and subjected to mass-spectrometry
and Gene Ontology analyses. This purification strategy is
highly specific, as confirmed by the presence of essential
regulators of fast axonal transport in the make-up of these
organelles. Our results indicate that signaling endosomes
undergo a rapid maturation with the acquisition of late
endosome markers following a specific time-dependent
kinetics. Strikingly, signaling endosomes are specifically
enriched in proteins known to be involved in neurodegen-
erative diseases and neuroinfection. Moreover, we high-
lighted the presence of novel components, whose precise
temporal recruitment on signaling endosomes might be
essential for proper sorting and/or transport of these or-
ganelles. This study provides the first quantitative pro-
teomic analysis of signaling endosomes isolated from
motor neurons and allows the assembly of a functional
map of these axonal carriers involved in long-range neu-
ronal signaling. Molecular & Cellular Proteomics 15:
10.1074/mcp.M115.051649, 542–557, 2016.
Intracellular communication is essential to maintain neuro-
nal homeostasis, differentiation and survival. Motor neurons
(MNs)1 are characterized by very long axons whose nerve
terminals can be as far as one meter away from the soma in
humans. These long distances require the development of
specialized mechanisms to ensure effective long-range com-
munication between axonal and somatodendritic compart-
ments. Fast axonal transport represents the backbone of
these trafficking mechanisms and is responsible for the shut-
tling of several types of organelles, proteins, and RNAs on
microtubule tracks (1, 2). Anterograde transport is mainly
driven by kinesin motors and ensures delivery of newly syn-
thesized proteins, synaptic vesicle precursors, lipids, and or-
ganelles to synapses and distal parts of dendrites. In contrast,
retrograde transport relies on cytoplasmic dynein for the
movement of mitochondria, autophagosomes, lysosomes,
and aging proteins targeted for degradation and/or recycling
from axon terminals to the soma. Other cargoes such as
neurotrophins (NTs) and their receptors are transported in a
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internalized in endocytic carriers and transported along the
axon to the soma, where they exert their trophic responses
(3, 4). These specialized organelles, the so-called signaling
endosomes, are key players in this process. On their delimit-
ing membrane, signaling endosomes host several factors re-
quired for NT signaling (2) and for their sorting and transport,
such as the small GTPases Rab5 and Rab7 (5, 6) (Fig. 1A).
Increasing evidence show that deficits in axonal transport
lead to neurodevelopmental and neurodegenerative diseases.
Mutations in molecular motors, their regulators, and cytoskel-
etal components have been associated with motor neuron
disease, Alzheimer’s disease and Huntington’s disease, to
cite a few (7, 8). Moreover, mutations in Rab proteins and their
regulating factors cause motor and sensory pathologies, such
as Charcot-Marie-Tooth type 2B (CMT2B) disease, which is
caused by mutations in Rab7 (9) and a familial form of amy-
otrophic lateral sclerosis (ALS), which is linked to mutations in
the Rab5 regulator alsin (10). Further links between motor
neuron disease and mutations of the dynein/dynactin com-
plex have also been reported (2, 11, 12).
Although several studies focused on unraveling the signal-
ing properties, the role of actin and microtubules-dependent
motors, and the sequential recruitment of Rab5 and Rab7-
GTPases on signaling endosomes (13) (Fig. 1A), little is known
about their molecular dynamics and temporal changes in their
composition during transport. Different approaches have
been pursued to investigate the composition of signaling en-
dosomes in neurons, ranging from the use of a sciatic cham-
ber (14), to subcellular fractionation and pull-down (15), im-
munoisolation (16), high-resolution organelle fractionation
(17), and, more recently, ferrofluid-mediated magnetic purifi-
cation (18). Those studies yielded new data regarding the
composition of signaling endosomes, yet a quantitative pro-
teomic approach would describe better the nature of those
endocytic and provide more details about their dynamics and
molecular make-up (19). Various mass spectrometry (MS)
strategies have been applied to study the molecular compo-
sition of purified synaptic vesicles (20) and synapses (21, 22),
NT signaling pathways (23), and to evaluate the functional
differences between primary MNs and MN-like cell lines (24).
Considering the established link between axonal transport
deficits and amyotrophic lateral sclerosis, a neurodegenera-
tive diseases affecting MNs (25), this type of neurons consti-
tute a model of choice to investigate the molecular composi-
tion of signaling endosomes and its modifications during
axonal transport. Temporal changes in the proteome can be
measured by Stable Isotope Labeling with Amino acids in Cell
culture (SILAC), a quantitative method involving metabolic
labeling, which allows the assessment of the relative abun-
dance of proteins and their changes in different experimental
conditions. Given their terminal differentiation, primary MNs
have low protein turnover rates, making it difficult to achieve
complete metabolic incorporation (26). We circumvented this
difficulty by developing SILAC protocols using mouse embry-
onic stem (ES) cell-derived MNs, in which labeled amino acid
incorporation was set up from the pluripotent stem cell stage,
allowing efficient labeling of the generated neurons. As de-
scribed previously (6, 27, 28), we exploited the ability of the
binding fragment of tetanus neurotoxin (HCT) to be internal-
ized in MNs and undergo axonal retrograde transport to per-
form pulse-chase experiments and purify HCT-containing en-
dosomes from SILAC-labeled cells. Gene Ontology (GO)
analysis showed that the signaling endosomes underwent a
fast maturation process, mediated by a progressive enrich-
ment of late endosome (LE)/lysosome markers. In addition,
our results indicated that several proteins reported to be
involved in pathologies affecting the nervous system are as-
sociated to signaling endosomes, emphasizing the patho-
physiological relevance of our study. Importantly, our data
also revealed potential new signaling endosome components,
whose temporal recruitment and/or function might be essen-
tial for axonal retrograde transport.
EXPERIMENTAL PROCEDURES
Cells and Reagents—Mouse ES cells were provided by the Crick
Institute Biological Resource Unit and were derived from hybrid blas-
tocysts generated by the mating of C57BL/6J and 129 (S6)SvEv mice
as previously described (29).
Unlabeled L-arginine and L-lysine, (R0K0, Sigma-Aldrich, Gilling-
ham, United Kingdom), medium L-arginine [13C6] and L-lysine [D4]
R6K4) and heavy L-arginine [13C6,
15N4] and L-lysine [
13C6,
15N2]
(R10K8) in their hydrochloride forms were obtained from CK Isotopes
(Ibstock, United Kingdom).
Rat antihemagglutinin (HA; Roche, Burgess Hill, West Sussex,
United Kingdom; 1:1000), rabbit anti-Arl8b (Biorbyt, Cambridge,
United Kingdom; 1:200), goat anti-LIMP2 and anti-CAR (R&D Sys-
tems, Abington, United Kingdom; both 1:100) primary antibodies
were used for immunofluorescence. For western blots, we used the
following: mouse anti-Rab5 (Synaptic Systems, Go¨ttingen, Germany;
1:500), rabbit anti-Rab7 (Cell Signaling Technology, Leiden, The
Netherlands; 1:1000), rabbit anti-Arl8b (1:500) (30), goat anti-CAR
(R&D Systems, 1:500) and mouse anti-III-tubulin (Covance, London,
United Kingdom; 1:1000).
Cell Culture, Differentiation, and Metabolic Labeling—ES cells were
grown for 4 days on 0.2% fish skin gelatin-coated flasks in SILAC
growth medium made of custom-made SILAC Dulbecco’s Modified
Eagle Medium:nutrient mixture F12 (DMEM/F12, AthenaES-Enzo Life
Sciences, Newmarket, United Kingdom) supplemented with light,
medium or heavy L-Arg (147.5 mg/L) and L-Lys (91.25 mg/L), 10%
KnockOut™ serum replacement (KOSR; Life Technologies, Paisley,
United Kingdom), 1% GlutaMAX™ (Life Technologies), 0.1 mM 2-mer-
captoethanol, and 1000 units/ml of ESGRO® recombinant leukemia
inhibitory factor (Millipore, Watford, United Kingdom). To generate
MNs, SILAC-ES cells were transferred to nontissue culture-treated
Petri dishes and grown in suspension in differentiation medium com-
posed of 45% custom-made SILAC Neurobasal® medium (Cell Ser-
vices, Crick Institute) supplemented with corresponding types of L-
Arg (84 mg/L) and L-Lys (146 mg/L), 45% SILAC DMEM/F12
supplemented with 147.5 mg/L of L-Arg and 91.25 mg/L of L-Lys,
10% KOSR, 0.4% GlutaMAX and 0.1 mM 2-mercaptoethanol (day 0 of
differentiation). At day 1, embryoid bodies (EBs) were gently centri-
fuged, resuspended in fresh SILAC differentiation medium and trans-
ferred to new Petri dishes. The following day (day 2), the enlarged EBs
were allowed to sediment by gravity before being re-suspended in
fresh SILAC differentiation medium supplemented with 1 M retinoic
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acid (RA; Sigma-Aldrich) and 333 nM Smoothened ligand SAG, a
chemical activator of sonic hedgehog signaling (Enzo Life Sciences).
EBs were maintained under these conditions for 4 days with medium
changed every day and then gently disaggregated at day 7 with
Accumax™ solution (Millipore). Dissociated cells were then plated
onto poly-D,L-ornithine and laminin (Sigma-Aldrich) coated dishes
and/or glass coverslips in SILAC MN growth medium made of 95%
supplemented SILAC Neurobasal® medium, completed with 2%
B27, 2% heat-inactivated dialyzed horse serum (1 kDa MWCO,
Dundee Cell Products, Dundee, United Kingdom), 1% GlutaMAX, 25
M 2-mercaptoethanol, 10 ng/ml rat ciliary neurotrophic factor (R&D
Systems), 0.1 ng/ml rat glial cell line-derived neurotrophic factor (R&D
Systems), and 1 M RA. Cells were maintained during 3 days in
culture (DIV3) before use.
Signaling Endosome Purification—Amino-derivatized monocrystal-
line iron oxide nanoparticles (MIONs, Kisker, Steinfurt, Germany) were
conjugated to cysteine-rich HA-tagged HCT or glutathione-S-trans-
ferase (GST) as previously described (6, 27). Briefly, 5 mg of MIONs
were activated with 1 mM EDTA and 3 mM succinimidyl 4-(N-maleim-
idomethyl)cyclohexane-1-carboxylate (Life Technologies) for 30 min
at 22 °C. After having repeated this step once, activated MIONs were
purified on a PD10 desalting column (GE Healthcare, Little Chalfont,
United Kingdom), concentrated and divided into two batches, which
were labeled for 2 days at 4 °C with 6 nmol of HCT or GST, both
previously reduced with 1 mM Tris(2-carboxyethyl)phosphine (TCEP;
Pierce, Paisley, United Kingdom) for 30 min at 22 °C. The reaction
was blocked by incubation with 2 mM reduced glutathione (Sigma-
Aldrich) for 1 h at 22 °C. Conjugated MIONs were purified on Sep-
hacryl S100HR (GE Healthcare).
The purification of MNs signaling endosomes was performed as
previously described (6, 27) with minor modifications. HCT-MIONs
and GST-MIONs were incubated with DIV3 ES-derived MN for 60 min
at 37 °C or pulsed for 10 min at 37 °C and then chased for 10, 30, and
60 min in complete MN medium. After internalization, MNs were
cooled on ice, acid-washed, washed with Hank’s balanced buffered
salt solution (HBSS) pH 7.4 and finally with breaking buffer (BB, 0.25
M sucrose, 10 mM Hepes-KOH, pH 7.2, 1 mM EDTA, 1 mM magnesium
acetate and protease inhibitors). Neurons were mechanically lysed in
BB by passing them 15 times through a cell cracker device (18 m
clearance; European Molecular Biology Laboratory, Heidelberg, Ger-
many) and clarified by centrifugation at 690  g for 10 min at 4 °C
(28).
For the SILAC experiment, the protein concentration of the three
post-nuclear supernatants (PNS) was determined using a BCA pro-
tein quantification assay (Life Technologies), and the three PNS were
mixed in 1:1:1 ratio. MS columns were placed inside a SuperMACS II
(both from Miltenyi Biotech, Bisley, United Kingdom) and equilibrated
with BB supplemented with 0.4% bovine serum albumin (BSA). The
sample was then passed three times through the column. After sev-
eral washes with BB, the columns were removed from the magnetic
field and the elution was performed using 1 ml BB containing 300 mM
KCl. Endosomal proteins were then precipitated and separated by
SDS-PAGE using 10% Bis-Tris gels (Life Technologies).
In-gel Digestion and LC-MS/MS—Polyacrylamide gel slices were
prepared for mass spectrometric analysis using the Janus liquid
handling system (Perkin-Elmer, Seer Green, United Kingdom). Briefly,
the excised protein gel piece was placed in a well of a 96-well
microtiter plate and destained with 50% acetonitrile, 50 mM ammo-
nium bicarbonate, reduced with 10 mM dithiothreitol, and alkylated
with 55 mM iodoacetamide. Proteins were digested with 6 ng/l
trypsin overnight at 37 °C. The resulting peptides were extracted in
2% formic acid, 1% acetonitrile.
For LC-MS/MS analysis, peptides were loaded on 50 cm Easy
Spray PepMap column (75 m inner diameter, 2 m particle size,
Thermo Fisher, Paisley, United Kingdom) equipped with an integrated
electrospray emitter. Reverse phase chromatography was performed
using the RSLC nano U3000 (Thermo Fisher) with a binary buffer
system at a flow rate of 250 nl/min. Solvent A was 0.1% formic acid,
5% dimethylsufoxide (DMSO), and solvent B was 80% acetonitrile,
0.1% formic acid, 5% DMSO. The in-gel digested samples were run
on a linear gradient of solvent B (2–40%) in 65 min, total run time of
90 min including column conditioning. The Q Exactive was operated
in data-dependent mode acquiring HCD MS/MS scans (r  17,500)
after an MS1 scan (r  70,000) on the ten most abundant ions using
MS1 target of 1  106 ions, and MS2 target of 5  104 ions. The
maximum ion injection time utilized for MS2 scans was 0.120 s, the
HCD normalized collision energy was set at 28, the dynamic exclusion
was set at 10 s, and the peptide match and isotope exclusion func-
tions were enabled.
MS Data Processing and Analysis—Raw data files were analyzed
with MaxQuant/Andromeda software (version 1.3.0.5). Parent ion and
tandem mass spectra were searched against M. musculus complete
proteome containing 77,938 protein sequences obtained from Uni-
protKB (release August 2012). A list of 247 common laboratory con-
taminants provided by MaxQuant/Andromeda was also added to the
database. The enzyme specificity was set to trypsin with a maximum
of two missed cleavages. The precursor mass tolerance was set to 20
ppm for the first search (used for mass recalibration) and to 6 ppm for
the main search. The tolerance for fragment ions was set at 20 ppm.
Carbamidomethylation of cysteines was specified as fixed modifica-
tion, oxidized methionines and N-terminal protein acetylation were
searched as variable modifications. The datasets were filtered on
posterior error probability (PEP) to achieve 1% false discovery rate on
protein and peptide levels (56). Briefly, posterior error probabilities
(PEP) were calculated for all peptide spectrum matches (PSMs;
supplemental Table 1). The database containing all true protein se-
quences was concatenated with a decoy database containing re-
versed nonsense version of the sequences. The PEP scores were
used to sort the PSM from forward and reverse databases until the
desired FDR threshold is achieved (set at 1% for this study). The PEP
value for a certain protein was calculated by multiplying their peptide
PEPs and was used to sort the list of hits from forward and reverse
databases. This specific SILAC experiment was performed once and
the resulting raw data are available via the PRIDE database (http://
www.ebi.ac.uk/pride/archive/, project accession: PXD002111).
Bioinformatics and Gene Ontology Analysis—To analyze the cell
compartment distribution of SILAC proteins, all quantified proteins
were annotated using M. musculus ontology gene sets downloaded
from QuickGO (http://www.ebi.ac.uk/QuickGO/). The LE/lysosome
gene set was obtained by merging LE and lysosome gene sets
provided by QuickGO.
The enrichment of proteins (unique gene symbols) from the SILAC
experiment was assessed using the “phyper” function in Bioconduc-
tor version 3 running R version 3.1.2. The function uses a hypergeo-
metric test to evaluate the enrichment of proteins within the experi-
ment relative to the mouse proteome for each GO set. All UniProtKB
mouse identifiers mapped to unique gene symbols were used as the
background. Disease and biological processes enrichment were as-
sessed using a hypergeometric test, with the Metacore analysis soft-
ware (http://www.Thompsonreuters.com). p values are multiple-test-
ing corrected using the Benjamini-Hochberg method, where p  0.05
are significant.
Western Blotting—After protein precipitation, purified proteins
were separated by SDS-PAGE using NuPAGE Bis-Tris gradient gels
(Life Technologies) and blotted overnight at 4 °C onto polyvinylidene
fluoride membranes (GE Healthcare), according to the manufacturer’s
instructions. Membranes were blocked in 5% skimmed milk dissolved
in Tris-buffered saline containing 0.05% Tween-20 (TBST) for 1 h at
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room temperature and then incubated with primary antibodies in
TBST or TBST 5% skimmed milk overnight at 4 °C. Blots were then
washed and incubated with appropriate horseradish peroxidase-
conjugated secondary antibodies (GE Healthcare). Immunoreactiv-
ity was detected using enhanced chemiluminescence (Millipore and
GE Healthcare).
Immunofluorescence and Confocal Microscopy—DIV3 ES-derived
MNs plated on coverslips were incubated with HA-tagged HCT for 60
min at 37 °C or pulsed for 10 min at 37 °C, then chased for 10, 30, or
60 min in complete MN medium. After internalization, MNs were
cooled on ice, acid-washed and washed with HBSS. Cells were then
fixed in 4% paraformaldehyde in HBSS, quenched with 50 mM NH4Cl,
pH 7.5, and permeabilized with 0.1% Triton X-100 in PBS. After
blocking in PBS containing 5% BSA for 1 h at 25 °C, coverslips were
incubated overnight at 4 °C with primary antibodies diluted in block-
ing buffer, washed and incubated with AlexaFluor-conjugated sec-
ondary antibodies (Life Technologies, 1:250 or 1:500) for 1 h at 25 °C.
After several washes, coverslips were mounted in mowiol and con-
focal images were acquired using a Zeiss LSM780 equipped with a
Plan-Apochromat 63x/1.40 oil DIC M27 objective. Images were then
analyzed with Image J. The degree of colocalization between HA-HCT
and other signaling endosome components was assessed by deter-
mining the Manders’ coefficient using Image J. In the Arl8b validation
experiment, the significance was assessed using one-way ANOVA
(*  0.05) followed by Dunnett’s multiple comparisons test using the
10 min time point as reference.
RESULTS
HCT as an Effective Tool to Monitor Axonal Retrograde
Transport of Signaling Endosomes—Tetanus neurotoxin
(TeNT) as well as its HCT binding fragment binds specifically
to MNs at the neuromuscular junction, where it is internalized
by clathrin-mediated endocytosis and retrogradely trans-
ported to the soma by axonal signaling endosomes. These
organelles are characterized by long-range signaling activity,
which enables specific transcriptional responses in the soma
(13). Previous studies showed that HCT shares axonal trans-
port carriers with NTs and their receptors in MNs and sensory
neurons (31), making HCT a useful tool to visualize signaling
endosomes and map their journey along the axon. At early
time points after internalization, HCT-containing endosomes
undergo slow short-range movements and are characterized
by the presence of Rab5 on their limiting membrane (10 min;
Fig. 1A). Rab5 is then exchanged with Rab7, a LE/lysosome
marker, in a process that is required for fast axonal retrograde
transport of these organelles to the soma (30 min; Fig. 1A) (6).
Once they reached the soma, HCT and NT-receptor com-
plexes are sorted to different fates: activated NT receptors are
mainly sent to degradation (32), whereas HCT remains in
nonacidic compartments (31, 33) and is transcytosed to ad-
jacent interneurons (60 min; Fig. 1A). Although several studies
used HCT as a probe to characterize retrograde carriers (6, 27,
28) little is known about the late sorting events occurring in
signaling endosomes once they reach the soma, as well as
the dynamic changes taking place during transport. Our study
aims at unravel these mechanisms using HCT to isolate sig-
naling endosomes from ES-derived MNs and analyze their
molecular composition during axonal transport.
Development of a SILAC Protocol for ES-derived Motor
Neurons—SILAC is based on the incorporation of amino acids
labeled with stable isotopes into the whole proteome. In our
case, three different isotopologs of arginine and lysine were
used to investigate three different time points after HCT inter-
nalization (10, 30, and 60 min; Fig. 1B). Using SILAC, the
experimental variability between different samples and sepa-
rate MS analyses are considerably reduced compared with
conventional label-free MS approaches. However, the suc-
cess of SILAC relies on the complete incorporation of medium
and heavy amino acids during protein turnover, and therefore,
depends on the degree of cell proliferation (34). In this regard,
post-mitotic cells such as neurons are potentially problematic
because of the expected low percentage of incorporation
during the time frame of the experiment. Nevertheless, SILAC
protocols have been successfully adapted to primary neurons
by adopting ad-hoc normalization procedures or careful op-
timization, such as longer culturing times to achieve accept-
able percentages of incorporation (23, 26, 35).
These experimental difficulties have been bypassed by us-
ing MN-like cells, which can be indefinitely propagated in
culture, and are well suited for biochemistry and high-
throughput analyses. Although MN-like cells have been ex-
tensively used to study NT trafficking, MN function and path-
ological mechanisms (36, 37), their physiological relevance
has been challenged because of major differences with pri-
mary MNs such as lack of specific neuronal markers and
distinct regulation of key signaling pathways involved in neu-
rodegeneration (24). To overcome these shortcomings, we
decided to use MNs differentiated from mouse ES cells, using
a modified version of the protocol described by Wichterle et
al. (38). This well-established technique leads to the genera-
tion of 20–30% of MNs, exhibiting the same morphology,
lineage markers and functional properties than primary spinal
cord MNs (38–40). We obtained about 20% of MNs, as as-
sessed by the expression of the MN specific markers HB9,
Islet1/2 and choline acetyltransferase (ChAT) (supplemental
Fig. S1A and B ). These cells are able to internalize efficiently
HCT, which accumulates in the perinuclear region of MNs
(supplemental Fig. S1B) (31, 33). In contrast, HCT does not
bind and/or undergo endocytosis in glial cells (asterisks; sup-
plemental Fig. S1B). Because our aim was to analyze the
composition of a relatively rare intracellular organelle, getting
a high yield of MNs was essential to secure a sufficient
amount of protein samples to provide reliable MS identifica-
tion and quantification.
We opted for an extended incorporation kinetics spanning
from ES cells to fully differentiated MNs. We started the
incorporation of light (R0K0), medium (R6K4), and heavy
(R10K8) amino acids into ES cells, 4 days before initiating the
differentiation process (Fig. 1B), during which the labeled
amino acids were kept in the culture media. Although at least
six cell division cycles were recommended to achieve 90%
of incorporation (41), we were able to achieve a percentage of
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FIG. 1. Axonal transport of signaling endosomes and their analysis via SILAC. A, Schematics summarizing current understanding on the
trafficking of NTs, HCT and their receptors in MNs. At the neuromuscular junction (NMJ), HCT binds its plasma membrane receptors (71),
whereas NTs bind Trks and p75NTR. Both complexes are rapidly internalized in clathrin-coated vesicles (CCV) before reaching a Rab5-positive
early endosomal compartment characterized by slow short-range movements (10 min). Upon recruitment of Rab7 (30 min), signaling
endosomes undergo microtubule-dependent fast axonal transport driven by cytoplasmic dynein. Once the soma is reached (60 min), receptor
complexes are sorted to different fates: activated NT receptors are sent to degradation and/or recycled to the plasma membrane, whereas HCT
complexes accumulate in perinuclear nonacidic compartments and/or undergo transcytosis to enter neighboring inhibitory interneurons. A full
characterization of the somatic sorting compartment is still lacking. HCT: binding fragment of tetanus neurotoxin; HCT-R: HCT receptor
complex; NT: neurotrophin, p75NTR; p75 neurotrophin receptor, Trk: tropomyosin receptor kinase; 5: Rab5; 7: Rab7. B, SILAC workflow.
Label-free ES cells were split into three different ES cultures and each of them was incubated with light (R0K0), medium (R6K4) or heavy
(R10K8) amino acids-supplemented growth medium for 4 days. ES cells were then subjected to an optimized MN differentiation protocol during
which the labeled isotopes were maintained in the respective differentiation medias. At day 7 of differentiation, MNs were disaggregated,
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incorporation close to 98% at day 2 of the differentiation
process (data not shown). This high incorporation efficiency
might be explained by the sustained growth of ES cells during
the first 2 days of differentiation. No difference was observed
in terms of ES cell morphology, cell division, or differentiation
ability in the SILAC media (data not shown), confirming that
the chosen SILAC conditions do not have discernable phe-
notypic effects on these processes (42). Notably, these label-
ing conditions allowed us to achieve an incorporation of
nearly 100% in ES-derived MNs, with a negligible arginine to
proline conversion rate, a known shortcoming of this proce-
dure (supplemental Fig. S2). As observed for ES cells, MNs
maintained in SILAC medium did not exhibit any overt mor-
phological difference, and their ability to bind and internalize
HCT was equivalent to control cells (data not shown).
These results indicate that we established a reliable SILAC
protocol for the labeling of mouse ES cells and ES-derived
MNs, which preserves the pluripotency and self-renewal
properties of ES cells that retain their ability to differentiate
into MNs.
Signaling Endosomes Purification and SILAC Quantifica-
tion—To isolate signaling endosomes from ES-derived MNs,
we first coupled HCT and GST to super-paramagnetic
monocrystalline iron oxide nanoparticles (MIONs) (6, 27). To
assess the specificity of our purification strategy, we per-
formed a pilot experiment in which HCT-conjugated MIONs
were internalized for 60 min in unlabeled ES-derived MNs. The
specificity of internalization was assessed by using MIONs
conjugated to glutathione S-transferase (GST), a protein that
is not internalized in MNs by receptor-mediated endocytosis
(data not shown). Proteins associated to GST-MIONs are
potential contaminant proteins, and were labeled accordingly
in supplemental Table S1. The efficiency and specificity of
HCT-MIONs internalization in MNs was also verified by immu-
nofluorescence (supplemental Fig. S3) and the composition of
purified carriers was assessed by Western blotting. Estab-
lished markers of signaling endosomes, such as cytoplasmic
dynein, a microtubule-dependent molecular motor, and the
small GTPase Rab5 were associated with the HCT-MIONs
sample but not with control MIONs, showing the specificity of
our purification strategy (Fig. 1C).
In the SILAC experiment, we followed a pulse-chase pro-
cedure, where light (L), medium (M) and heavy (H) ES-derived
MNs were incubated with HCT-MIONs for 10 min, 30 min, and
60 min respectively (Fig. 1B), before being washed and me-
chanically lysed. Post-nuclear supernatants were mixed 1:1:1
and submitted to a magnetic isolation process, from which
HCT-MIONs-containing endosomes were purified (6). After
electrophoretic separation, protein samples underwent in-gel
tryptic digestion and peptide mixtures were subjected to mul-
tiplexed MS analysis using SILAC. As multiplexing occurred
prior to MS analysis, the three mixed populations of proteins
from L, M, and H samples underwent identical preparation
steps until they appeared as separate peptide intensity sig-
nals in the mass spectrometer. The advantage of this method
is that labeling and mixing were done early in our workflow,
thereby keeping technical variation to a minimum. Triplex
intensity peaks in MS1 also informed on peptide amino acid
composition as they revealed the number of arginine and
lysine present in the peptides, a value that is used as a MS2
database search constraint by the MaxQuant/Andromeda
software. MS1 signal that was not identified by MS2 database
search could still be used for quantification, because Max-
Quant would predict the location of peptide isotopologs in the
LC-MS datafile with great accuracy through mass and reten-
tion time correlation. Thus, compared with label-free meth-
ods, fewer missing values were provided, thereby facilitating
downstream analysis and interpretation of the data.
We identified 2306 proteins (estimated false discovery rate,
FDR: 1%), of which 2262 were quantified. Three different
SILAC ratios, corresponding to the three different time points
of HCT internalization, were determined by MaxQuant: M/L,
H/M, and H/L (M/L, 30 min/10 min; H/M, 60 min/30 min; H/L,
60 min/10 min). All time point log2 ratios approximately fol-
lowed a normal distribution with relatively few outliers (Fig.
2A). Fig. 2B shows the distribution of the proteins as a func-
tion of their 30 min/10 min and 60 min/10 min fold changes
(FC) during the time-course. In the same figure are highlighted
possible contaminants (Fig. 2B; red dots), which were se-
lected based on their higher abundance in the GST-MIONs
sample (supplemental Table S1). These proteins might be
implicated in the fluid-phase uptake of GST-MIONs and were
not further analyzed in this study. The low abundance of those
proteins (31%) compared with the total MS data under-
scores the specificity of our purification technique. As shown
in Fig. 2B, the abundance ratios of most of the signaling
endosome-associated proteins remained constant during in-
ternalization and transport, as exhibited by the cloud of data
points close to 1.0 FC. Notably, a pool of outliers was ob-
served on the top-right end of the plot, which corresponds to
proteins that accumulate in signaling endosomes at late time
points in the trafficking process. The size of each point in this
plated in MN medium supplemented with corresponding SILAC-labeled amino acids and maintained for 3 days (left panel, I). DIV3 MNs were
pulsed for 10 min with HCT-conjugated MIONs and chased for 10, 30, or 60 min. MNs were then acid-washed, mechanically lysed, and cell
homogenates were clarified by centrifugation. Postnuclear supernatants were pooled 1:1:1, and the resulting combined sample was submitted
to magnetic purification protocol, as described under “Experimental Procedures” (right panel, II). C, Specificity of the purification strategy. DIV3
ES-derived MNs were incubated for 60 min at 37 °C with HCT- or GST-conjugated MIONs, acid-washed, and submitted to magnetic endosome
purification. The inputs (post-nuclear supernatants, 3% of total) and the whole 60 min eluates were then separated by SDS-PAGE and analyzed
by western blotting. MW: molecular weight, DIC, dynein intermediate chain.
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plot reflects its relative intensity, with bigger point sizes relat-
ing to proteins with high intensities and therefore likely to be
highly abundant in the purified signaling endosomes. In addi-
tion, proteins with high intensities were generally associated
with multiple quantifications, making our data more reliable.
Few potential contaminants were found in this pool of outliers,
making the majority of proteins in this pool highly specific. In
addition, these proteins were highly abundant and their asso-
ciation to the signaling endosomes was time-dependent.
Cell Compartment Distribution of Signaling Endosome-
Containing Proteins—To better characterize the identified sig-
naling endosome components, we performed gene ontology
(GO) analyses on the quantified proteins. We noticed that
several early endosome markers were present but most of
them clustered around the cloud of data close to 1.0 FC,
suggesting that they remained relatively constant throughout
trafficking and signaling endosome maturation (Fig. 3A), as
seen for the small GTPase Rab5 (60/10 ratio: 0.80; supple-
mental Table S1). These results confirmed previous data
showing that Rab5 was associated to HCT-positive endo-
somes at early time-points after internalization, during which
these organelles were stationary or displayed localized short-
range movement in axons (6).
The abundance of a set of proteins clustered at the bottom
left of the plot decreased with time, suggesting that they
constitute a potential pool of early components enriched at 10
min of internalization (supplemental Fig. S4 and supplemental
Table S2). Although these proteins might play a role in early
steps of HCT-MIONs internalization, we focused our analyses
on proteins accumulating on signaling endosomes, whose
recruitment might be instrumental for their maturation and
trafficking toward the cell body.
After internalization, the acquisition of the late LE marker
Rab7 allows these HCT carriers to undergo fast axonal trans-
port toward the cell body (Fig. 1A) (6). Accordingly, several
LE/lysosome markers were recruited very early in the biogen-
esis of signaling endosomes in addition to Rab7 (Fig. 3B),
whose abundance already increased between 10 and 30 min
(30/10 ratio: 1.48; supplemental Table S1). This result fits with
the observed lag phase in the onset of fast axonal transport,
which usually last between 15 min and 20 min (31). SNX16, a
protein of the sorting nexin family, is recruited with the early
markers between 10 min and 30 min, and its abundance
increases afterward (30/10, 60/30 and 60/10 ratios: 1.38, 2.06
and 2.87, respectively; supplemental Table S1), which is in
accordance with its distribution in both early and late endo-
somes and its role in the regulation of trafficking between
these two compartments (43). Therefore, the choice of a
narrow time course (10, 30 and 60 min) allowed us to provide
more accurate information about the kinetics of signaling
endosome transition from an early to a late stage. The ob-
served acquisition of LE determinants was confirmed by our
enrichment analysis showing that LE/lysosome markers ac-
cumulated in axonal retrograde carriers. Indeed, using a hy-
pergeometric test, we showed that among specific signaling
endosome proteins, 137 of them were part of LE/lysosome,
resulting in a highly significant enrichment (p value, 7.853 
1049).
Overall, we found that signaling endosomes contained sev-
eral plasma membrane proteins showing a significant time-
dependent ratio change (Fig. 3C). Most of these proteins were
also found in LE/lysosome compartments, reflecting the con-
tinuous cycling of many plasma membrane proteins through
LE. In addition, GO analysis indicated that numerous endo-
plasmic reticulum (ER) proteins were present in signaling en-
dosomes (Fig. 3D), which could be because of the extensive
contact sites existing between ER and endosomes (44) and
plasma membrane and ER (45). Several proteins enlisted in
the ER and plasma membrane groups were also found in our
list of potential contaminants, together with proteins normally
localized in the nucleus and mitochondria (supplemental Ta-
ble S1). Their presence among specific carrier components
could be explained at least in part by the extensive contact
sites existing between different organelles (45), but also by the
multiple compartment localization of some of these proteins,
such as superoxide dismutase 1 (SOD1), whose mutations
lead to ALS (25) (supplemental Table S1). However, very few
specific proteins from this outlier population belong to mito-
FIG. 2. SILAC analysis. A, Normal distribution of the log2 ratios of
30 min/10 min proteome (top) and 60 min/10 min proteome (bottom).
B, SILAC fold change (FC) scatter plot. X-axis (M/L: 30 min/10 min).
Y-axis (H/L: 60 min/10 min). Proteins associated with high intensities
as determined by the MaxQuant/Andromeda software are plotted
with larger point sizes. Proteins on the red dotted line are character-
ized by identical M and H values. Potential nonspecific proteins are in
red.
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chondrial or nuclear compartments (supplemental Fig. S5A
and S5B, respectively), further confirming their specificity.
Several ribosomal proteins were identified in purified sig-
naling endosomes (supplemental Table S1). Although their
high abundance makes them often come up as false positive
in MS experiments, ribosomal proteins might also be genuine
components of retrograde carriers, as suggested by the re-
cent report showing the association of ribosomes with motile
endosomes, which links mRNA translation to endosome
transport (46–48).
Altogether, our data suggest that after HCT-MIONs internal-
ization, signaling endosomes were rapidly enriched in LE/
lysosomal markers, which show their maturation during their
journey to the soma.
Enrichment of Signaling Endosomes with Protein Implicated
in Human Disease—Several studies have shown that neuro-
FIG. 3. Cell compartment distribution of signaling endosome components by Gene Ontology analysis. QuickGO terms were overlaid
onto the SILAC FC scatter plot, from which potential nonspecific proteins had been removed. A, Early endosome. B, Late endosome/
Lysosome. C, Plasma membrane, D, Endoplasmic reticulum. The proteins of a given compartment are highlighted in purple and annotated with
corresponding gene names. Candidates of particular interest (Rab7 and Arl8b) are highlighted in blue in B.
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degeneration may be linked to axonal transport deficits
caused by mutations in genes coding for proteins involved in
organelle trafficking, such as molecular motors, motor adaptors
and regulators, and cytoskeletal components (7, 8, 49). To
investigate whether signaling endosomes are significantly en-
riched for proteins associated with human pathologies, we per-
formed enrichment analysis using GeneGO and Metacore on-
tology for diseases. As shown in Table I, signaling endosomes
were significantly enriched (p value0.05) in proteins known to
be involved in neurological disorders, such as Alzheimer’s dis-
ease, Huntington’s disease, motor neuron disease including
ALS and tauopathies, which have all been associated with
altered axonal transport. This result confirmed that several sig-
naling endosome proteins are linked to neurodegeneration, and
that an alteration of their temporal-dependent association with
the carriers might lead to axonal transport deficits.
Bacterial and viral entry into the central nervous system
(CNS) is also likely to be associated with signaling endosome
trafficking (4), because several receptors for neurotropic
pathogens are found in these organelles (Table II). Indeed,
many pathogens have the ability to hijack the axonal transport
pathway to access the CNS, tetanus neurotoxin being one of
the best examples (50). We found that the synaptic vesicle
proteins synaptotagmins 1 and 2 and SV2A, which function as
the receptors of botulinum neurotoxins, were associated to
signaling endosomes, a finding which may explain the central
effects of these neurotoxins (51). Similarly, it had been shown
that several neurotropic viruses bind their receptors at axon
terminals and enter endosomes traveling to the neuron soma
(4). Our study shows that signaling endosomes host proteins
involved in viral CNS infections (Table II). Indeed, the cox-
sackie and adenovirus (CAV) receptor CAR is a highly abun-
dant signaling endosome component (Fig. 4A, (52)) and like
the enterovirus 71 receptor LIMP2 (lysosomal integral mem-
brane protein 2) (53), was found to colocalize with HCT in
axonal carriers (Fig. 4A and 4B), as shown in the quantification
displayed in Fig. 4D. Importantly, these results are in accord-
ance with previous studies showing that CAV, enterovirus 71
and poliovirus undergo axonal retrograde transport in MNs (4,
52, 54).
TABLE I
Association of signaling endosome components with human pathol-
ogies. Disease enrichment analysis was performed with Metacore
using a hypergeometric test. The ratios between endosomal protein-
coding genes and independent genes indicate the possible associa-
tion of any given gene with neurological diseases. Selected genesets
are listed in order of their statistical significance after Benjamini-
Hochberg correction. p values  0.05 are significant. Neurological
diseases associated with axonal transport deficits are highlighted in
bold. Neurological infections are marked with asterisks. Adj.p.value:
adjusted p value
Disease name adj.p.val Ratio
Central nervous system Diseases 1.89E-47 459/3069
Brain diseases 6.73E-46 435/2880
Schizophrenia 6.25E-43 203/914
Schizophrenia and disorders with
psychotic features
9.56E-43 203/918
Neurodegenerative diseases 2.74E-39 336/2104
Mental disorders 3.50E-39 281/1614
Nervous system diseases 3.50E-39 665/5522
Psychiatry and psychology 8.79E-36 307/1919
Dementia 9.48E-32 255/1536
Tauopathies 6.13E-29 206/1166
Alzheimer’s disease 2.04E-27 201/1153
Virus diseases* 1.68E-17 215/1531
TDP-43 proteinopathies 2.55E-17 54/180
Amyotrophic lateral sclerosis 9.00E-17 53/179
Heredodegenerative disorders,
nervous system
1.19E-16 163/1064
Glioblastoma 7.15E-16 311/2579
Astrocytoma 9.92E-16 315/2628
Epilepsy 1.09E-15 90/455
Basal ganglia diseases 5.70E-15 129/799
Movement disorders 3.01E-14 135/871
Neuromuscular diseases 1.31E-13 176/1278
Spinal cord diseases 2.14E-13 72/352
Neurologic manifestations 2.38E-13 204/1566
Motor neuron disease 2.76E-13 59/257
Tay-Sachs disease 8.24E-13 12/12
Dyskinesias 8.98E-13 117/745
Brain diseases, metabolic 1.71E-12 62/290
Bacterial infections and mycoses* 1.76E-12 175/1307
Glioma 2.44E-12 534/5313
RNA virus infections* 4.27E-12 148/1055
Brain diseases, metabolic, inborn 9.98E-12 59/279
Neoplasms, neuroepithelial 1.00E-11 554/5596
Infection* 7.58E-11 157/1185
Down syndrome 1.94E-10 42/173
Huntington’s disease 4.97E-09 75/461
Lysosomal storage diseases,
Nervous system
5.14E-09 23/67
Parkinsonian disorders 2.45E-05 58/405
Frontotemporal lobar
Degeneration
2.24E-04 18/80
Frontotemporal dementia 2.24E-04 18/80
TABLE II
Signaling endosomes and infection. Neurotropic pathogen receptors
present in signaling endosomes are listed together with their corre-
sponding viral or bacterial pathogen. Gene names are indicated in
brackets. With the exception of LIMP2, the abundance of these
receptors in signaling endosomes remains constant during axonal
transport
Pathogenic agent Receptor (gene)
Adenovirus CAR (Cxadr)
Coxsackievirus B CAR (Cxadr)
Poliovirus PVR (PVR)
Herpes Simplex virus Nectin-1 (Pvrl1)
Pseudorabies virus Nectin-1 (Pvrl1)
Rabies virus p75NTR (Ngfr)
Rabies virus NCAM (Ncam)
Enterovirus 71 LIMP2 (Scarb2)
Chikungunya virus Prohibitin (Phb)
Hendra virus/Nipah virus EphrinB2 (Ephb2)
Nipah virus EphrinB3 (Ephb3)
Junìn virus CACNA2D2 (Cacna2d2)
Botulinum neurotoxin B/G/DC Synaptotagmin 1/2 (Syt1/2)
Botulinum neurotoxin A/E/F SV2A (Sv2a)
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Dynamic Changes of Signaling Endosomes Proteins During
Axonal Transport—After assessing the molecular composition
of signaling endosomes, we investigated the dynamic
changes occurring in their associated proteins during axonal
transport. For this analysis, we focused on proteins that
showed a temporal dependence, chosen according to the
significance score (significance B) of their fold change ratio.
Significance B was calculated following a MaxQuant method
based on signal intensities, with the more significant fold
changes corresponding to the more abundant proteins (55).
These calculations allowed us to consider the group of pro-
teins that had significant increased and/or decreased ratios at
60 or 30 min compared with the 10 min time point (supple-
mental Fig. S6A and S6B; supplemental Table S1). We found
that 260 proteins (plus two isoforms) met these criteria (sup-
plemental Fig. S6C and supplemental Table S3). This dataset
included most of the proteins that would constitute candi-
dates of interest in the maturation of signaling endosomes as
FIG. 4. Association of viral receptors with signaling endosomes. A, DIV3 ES-derived MNs were incubated for 60 min at 37 °C with HCT- or
GST-conjugated MIONs, acid-washed and submitted to magnetic endosome purification. The inputs (post-nuclear supernatants, 2% of total) and
the whole 60 min eluates were then separated by SDS-PAGE and analyzed by western blotting to assess the presence of CAR (top). III-tubulin
(bottom) was used as a loading control. A star indicates the glycosylated form of CAR, a modification that could strengthen the binding of CAV and
stabilize the complex in the carriers for transport. MW: molecular weight. B, C, DIV3 ES-derived MNs were incubated with HCT for 60 min at 37 °C,
acid-washed, fixed and processed by immunofluorescence to detect HA-HCT-MIONs and CAR (B) or LIMP2 (C). Single plane images of cell bodies
(i) and neurites (ii) are shown. Examples of organelles positive for HCT and CAR or LIMP2 are indicated by arrowheads. Significant co-distribution
was noticed in somas and neurites for both candidates. Scale bars: 5 m. The overall degree of colocalization between HCT and CAR or LIMP2
was quantified and the corresponding Menders coefficients are shown in D. Error bar: standard error of the mean.
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indicated by their gene annotations (Fig. 3B and supplemental
Table S3). Enrichment analysis revealed that several proteins
are involved in intracellular transport, lysosome organization,
neuronal development and differentiation (Table III). The pres-
ence of the latter group of proteins is not surprising because
axon guidance and neurite outgrowth rely on axonal transport
(56). Overall, changing proteins could be grouped into six
clusters, following their trend change during the time-course,
i.e. exhibiting a constant increase or decrease throughout the
kinetics, exhibiting increasing then decreasing abundance
and vice-versa, or exhibiting temporal dependence at only
one time point, as displayed by the heatmap in supplemental
Fig. S7.
We focused on LE/lysosome proteins (Fig. 3B) whose abun-
dance significantly increased from 10 to 30 min and/or from
10 to 60 min. In fact, the recruitment of many LE components
continued to increase after 30 min (Fig. 3B and supplemental
Table S3). Among these, we identified well-known endolyso-
somal proteins, such as members of the lysosome-associated
membrane glycoprotein (LAMP) and LIMP families (LAMP1,
LAMP2: 30/10 ratios: 1.96 and 1.78; 60/10 ratios: 3.10 and
3.08; 60/30 ratios: 1.59 and 1.73 respectively; and LIMP2:
30/10 ratio: 2.34; 60/10 ratio: 4.49; 60/30 ratio: 1.94, supple-
mental Table S3). Vti1b, a v-SNARE involved in LE homotypic
fusion and in LE-lysosome fusion (57), was also found in
signaling endosomes, and exhibited progressive enrichment
in these organelles (30/10 ratio: 1.58; 60/10 ratio: 2.20; sup-
plemental Table S3). In addition, we identified the small GT-
Pase Arl8b, which exhibited similar ratios (30/10 ratio: 1.57;
60/10 ratio: 2.29; 60/30 ratio: 1.47, supplemental Table S3),
consistent with its key role in lysosome biogenesis and mo-
tility and LE/lysosome fusion (30, 58, 59). Arl8b is significantly
recruited to signaling endosomes during maturation, which
may be related to its putative function in axonal transport (60).
Among the increasing late components, we also identified the
LE/lysosome adaptor proteins LAMTOR1 and 2 (30/10 ratios:
2.08 and 2.42; 60/10 ratios: 3.42 and 3.82, respectively; sup-
plemental Table S3), which were implicated in signal trans-
duction from this compartment (61). The LE marker Rab7
displayed a significant increase only at 30 min and remained
relatively stable thereafter (30/10 ratio: 1.48; 60/10 ratio: 1.47;
supplemental Table S3), which suggests that it is a stable
component of retrograde carriers upon its recruitment at axon
terminals (Fig. 1A).
Biological Validation of Identified Signaling Endosome
Components and Their Recruitment Kinetics—To confirm the
SILAC data, we selected specific signaling endosome com-
ponents and checked for their presence and temporal-de-
pendent changes by western blotting and immunofluores-
cence. To independently confirm the SILAC results, we
repeated the internalization kinetics and purification experi-
ment in label-free conditions. ES-derived MNs were pulse-
chased with HCT-MIONs for 10, 30 and 60 min, or GST-
MIONs for 60 min. We confirmed that the early endosome
marker Rab5 was specifically enriched in samples isolated
with HCT-MIONs, but not in GST-MION controls (Fig. 5), fur-
ther emphasizing the specificity of our purification strategy.
Notably, the association of Rab5 to HCT-MION-containing
organelles did not change with time (Fig. 5). In agreement with
its essential role in the onset of axonal retrograde transport,
we observed a time-dependent recruitment of Rab7, with a
strong increase especially between 10 and 30 min (Fig. 5), a
change that correlates well with the observed 60/10 fold-
change of 1.47 obtained with the SILAC experiment (supple-
mental Table S3). The LE/lysosomal protein Arl8b was also
progressively recruited to the HCT-retrograde carriers, as
showed by a 60/10 SILAC ratio of 2.29 (Fig. 5 and supple-
mental Table S3). The abundance of these proteins was nor-
malized to III-tubulin, a neuronal-specific marker, which re-
TABLE III
Dynamic changes of signaling endosome components and biological
processes. Biological processes enrichment was performed similarly
to the disease enrichment analysis shown in Table II using a hypergeo-
metric test and the Metacore software. Biological processes that
involve transport mechanisms are highlighted in bold. GO: gene on-
tology. Adj.p.value: adjusted p value
GO Processes name ad.p.val Ratio
Cellular component
organization
3.24E-17 158/6165
Small molecule metabolic
process
1.33E-14 92/2752
Transport 1.52E-12 123/4781
Nervous system development 1.66E-12 91/2979
Cell projection organization 2.35E-11 55/1361
Cell morphogenesis involved in
neuron differentiation
2.61E-11 39/727
Neuron development 2.89E-11 51/1201
Neuron projection development 3.82E-11 45/966
Neuron projection
morphogenesis
5.51E-11 39/750
Cellular localization 5.51E-11 83/2766
Catabolic process 4.63E-10 69/2162
Axon development 4.85E-10 37/738
Brain development 5.22E-10 44/1016
Neuron differentiation 2.13E-09 53/1462
Generation of neurons 4.50E-09 63/1979
Sphingolipid catabolic process 5.43E-09 9/28
Axonogenesis 7.38E-09 33/664
Vesicle-mediated transport 9.91E-09 53/1533
Membrane lipid catabolic process 9.91E-09 9/30
Neurogenesis 1.09E-08 64/2081
Central nervous system
development
1.74E-08 48/1326
Macromolecule localization 2.49E-08 72/2549
Secretion by cell 3.07E-08 32/669
Establishment of localization in
cell
3.10E-08 67/2297
Regulation of neuron projection
development
4.81E-08 27/497
Exocytosis 1.21E-07 24/415
Cellular catabolic process 1.44E-07 55/1766
Lysosome organization 2.35E-07 10/58
Lytic vacuole organization 2.35E-07 10/58
Neuron projection guidance 2.39E-07 27/541
Axon guidance 2.39E-07 27/541
Membrane organization 4.73E-07 41/1153
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mains constant during transport (60/10 ratio: 1.06; Fig. 5 and
supplemental Table S1). Western blot analysis of the same
samples confirmed the time-dependent recruitment of the LE
v-SNARE Vti1b to signaling endosomes from 10 min post-
internalization (data not shown), a result that confirms the
increase of SILAC ratios during endosomal maturation (60/10
ratio: 2.20, supplemental Table S3).
Furthermore, the SILAC results were independently con-
firmed by visualizing the recruitment of selected MS hits to
HCT-containing organelles using immunofluorescence. As
shown in Fig. 6, Arl8b did not display overt colocalization with
HCT in the soma at 10 min chase, whereas co-distribution was
observed in neurites (Figs. 6A, i and ii). However, the degree
of HCT-colocalization with Arl8b increased over time both in
neurites and the cell body (Fig. 6B, i and ii), and rose signifi-
cantly at 60 min, especially in the perinuclear region, where
HCT accumulated (Figs. 6C, i and ii; Fig. 6D).
Taken together, these experiments show that our purifica-
tion strategy and SILAC approach are highly specific. We
confirmed that the late marker Arl8b is progressively recruited
to signaling endosomes in motor neurons. Our observations
suggest that this novel component might play a pivotal role in
axonal retrograde transport and/or sorting events taking place
in the soma, with important consequences for the down-
stream signaling and fate of the cargoes of signaling
endosomes.
DISCUSSION
In this report, we describe the first quantitative proteomic
analysis of signaling endosomes isolated from MNs. Our re-
sults provide novel insights on the molecular composition of
these organelles and the spatiotemporal dynamics of axonal
transport. Our SILAC data show that signaling endosomes
acquire LE markers during their transport to the soma, and
provide new information about their maturation mechanism.
Signaling endosomes acquire LE markers between 10 and 30
min, a kinetics that closely overlap with the onset of fast axonal
transport, which occurs 20 min post-internalization (6, 62).
Signaling endosome maturation was confirmed by the in-
creasing recruitment of several LE/lysosome proteins, such as
Arl8b and Vti1b (Figs. 3B and 6; supplemental Table S1). A
possible explanation of the continuous increase of these pro-
teins during the time course of our analysis is that their re-
cruitment is functionally linked to the initiation and/or steady-
state support of fast retrograde transport, as previously
reported for Rab7 (6). Alternatively, the accumulation of HCT-
MIONs in Vti1b- (data not shown) and Arl8b-positive organ-
elles (Figs. 5 and 6) might indicate the acquisition of fusion
competence in preparation for sorting and/or fusion events
occurring upon their arrival in the MN soma. Although Arl8b
and Vti1b play essential roles in LE/lysosome fusion (57), the
transport and somatic sorting compartments entered by HCT
are not classical LE/lysosomes, because HCT carriers are not
acidified during transport (33). Because full length TeNT is
able to translocate through the endosomal membrane into the
cytoplasm at acidic pH (50), blocking the acidification of these
organelles traps TeNT in the endosomal lumen, halting its
transfer to adjacent neurons (31, 33).
Several distinct functions have been described for Arl8b,
including lysosome transport and fusion (30, 58, 59, 63), and
homotypic fusion and vacuole protein sorting (HOPS) com-
plex recruitment (63). Our results suggest that Arl8b may play
a role in the somatic sorting of signaling endosome cargo,
such as NT receptor complexes and HCT. Previous data
showing a possible role of Arl8b in axonal transport (60)
further strengthens our hypothesis. Because this route con-
trols the down-regulation of ligand-activated receptor com-
plexes and their signaling (28), the elucidation of the role of
Arl8b in this pathway might unveil key mechanisms involved in
the regulation of signaling endosome dynamics.
Our findings could provide novel insights on the underlying
mechanisms linking LE/lysosomal deficits to neurodegenera-
tion, as many proteins associated with LE/lysosome traffick-
ing and/or function are altered in neurological diseases (49).
Importantly, we showed that purified signaling endosomes
were enriched in proteins involved in neurological conditions
FIG. 5. Candidate validation by western blotting. DIV3 ES-derived MNs were incubated for 10 min at 37 °C with HCT- or GST-conjugated
MIONs, then chased for 10, 30, or 60 min at 37 °C and purified by magnetic separation. Input (post-nuclear supernatant, 1% of total) and
10/30/60 min HCT-MIONs and GST-MIONs eluates (33% of total) were then separated by 12% Bis-Tris SDS-PAGE to improve the separation
of closely related low molecular weight proteins, and analyzed by Western blotting to assess the presence of Rab5, Rab7, and Arl8b (top).
III-tubulin was used as a loading control. The 60 min/10 min SILAC ratios were added for temporal-change comparison.
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in which axonal transport deficits have been found, such as
ALS, Alzheimer’s, Huntington’s and Parkinson’s diseases, to
name a few (Table I). In Parkinson’s disease, mutations of
LE/lysosome proteins and motor complexes, such as LRRK2,
Vps35, DCTN1, have been previously documented (8, 49),
suggesting that LE sorting defect and axonal transport dis-
ruption could play a causal role in this pathology. Strikingly,
the lysosomal protein LIMP2 displayed a temporal-dependent
incorporation into signaling endosomes (Fig. 3B, 4C and sup-
plemental Table S1). This finding might have a wider physio-
logical importance, because genetic variations in the LIMP2
coding gene (Scarb2) have been linked to the development of
synucleinopathies (64). Given the variety of CNS pathologies
highlighted by our enrichment analysis, additional signaling
endosome components might be linked to other neurological
diseases. In this regard, it would be crucial to investigate
putative differences in the molecular composition and dynam-
ics of signaling endosomes in different neurological patholo-
gies. Our SILAC labeling strategy could easily be applied to
the wide array of ES cells isolated from different mouse mod-
els of neurodegeneration currently available. Mutant ES cells
could be used to generate differentiated neurons in SILAC
FIG. 6. Validation of Arl8b localization on signaling endosomes by immunofluorescence. DIV3 ES-derived MNs were incubated for 10 min
at 37 °C with HCT, and then chased for 10 (A), 30 (B), or 60 min (C) at 37 °C, acid-washed, fixed and processed by immunofluorescence to detect
HA-HCT and Arl8b. Single plane images of cell bodies (i) and neurites (ii) are shown. Example of organelles positive for HCT and Arl8b are indicated
by arrowheads. Codistribution was noticed in neurites at 10 min chase. The degree of HCT-Arl8b colocalization increased both in neurites and the
cell body over time, especially in the perinuclear HCT accumulation sites. Scale bars: 5 m. The degree of colocalization between HCT and Arl8b
increases significantly (*) at 60 min chase, as shown by the Menders coefficients in D. *  0.05. Error bar: standard error of the mean.
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media, from which axonal signaling endosomes could be
isolated. The comparative analysis of the proteome of these
organelles derived from wild type and mutant neurons could
be invaluable to assess quantitative and temporal changes
occurring in disease conditions. Complementary to this ap-
proach, human induced pluripotent cell-derived MNs (hiPSC
MNs) (65) may open the way for further applications of our
SILAC protocols to study molecular mechanisms leading to
ALS and neurodegeneration in human cells.
Our proteomic analyses revealed that signaling endosomes
carry many virus and virulence factor receptors (Table II),
supporting the hypothesis that many neurotropic viruses hi-
jack the signaling endosome pathway to enter the CNS (4).
We confirmed the presence of the coxsackie and adenovirus
receptor CAR in signaling endosomes and we showed that
the majority of this receptor is glycosylated (Fig. 4A), a mod-
ification that could stabilize virus binding (66) and therefore
ensure its efficient transport to the soma.
Along with CAR and poliovirus receptors, in our analysis we
found nectin-1, the receptor of herpes simplex viruses 1 and
2, two viruses that are also known to undergo retrograde
transport mainly in sensory neurons (67). The pseudorabies
virus receptor was also present in our dataset, in accordance
with its retrograde transport in neurons (67). Notably, two of
the three described receptors for rabies virus were also pres-
ent in signaling endosomes, p75NTR and neural cell adhesion
molecule (NCAM), a result consistent with the observed ax-
onal retrograde transport of rabies virus in MNs (68). Further-
more, the presence of LIMP2 in the carriers suggests that
enterovirus 71, which has been shown to bind this protein on
the cell surface (54), might also enter and spread through the
CNS in signaling endosomes (69). Emergent viruses such as
Chikungunya, Hendra or Nipah are likely to use the same entry
pathway because their receptors are also present in this com-
partment (Table II). The list of receptors we provided here is non
exhaustive and may be expanded as novel receptors of CNS
targeted viruses will be characterized. In this regard, we con-
firmed the presence of nidogen 1, a basal membrane protein,
which has recently been shown to act as a receptor for TeNT
(70), in our signaling endosome analysis (data not shown).
In conclusion, in this report we provide an optimized SILAC
labeling strategy for ES-derived MNs and a reliable method
for the purification and proteomic mapping of signaling endo-
somes. Our data constitute a valuable resource to further our
understanding of the molecular composition and dynamics of
these organelles and provide new insights on the mechanism
regulating their progression along the axonal transport route,
with direct links to a wide range of neurological pathologies,
including CNS infections and neurodegenerative diseases.
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